Literature DB >> 8039935

A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach.

M Tsuda1, M Karita, M G Morshed, K Okita, T Nakazawa.   

Abstract

The urease of Helicobacter pylori has been proposed to be one of its pathogenic factors. A kanamycin resistance determinant was inserted in a cloned urease gene, and transformation-mediated allelic exchange mutagenesis was carried out to introduce the disrupted gene into the corresponding wild-type chromosomal region of a clinical isolate of H. pylori, CPY3401. The resulting mutant, HPT73, had the null activity of urease. Nude mouse stomachs were challenged with these two isogenic strains to examine the role of urease in pathogenesis. Gastritis was found in the CPY3401-challenged stomachs, from which bacteria indistinguishable from CPY3401 were recovered. There was no gastritis in the HPT73-challenged stomachs, and we could not recover H. pylori from them. These results indicated that H. pylori urease is essential for colonizing the nude mouse stomach.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039935      PMCID: PMC303000          DOI: 10.1128/iai.62.8.3586-3589.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets.

Authors:  K A Eaton; C L Brooks; D R Morgan; S Krakowka
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 2.  Pathogenicity of Helicobacter pylori: a perspective.

Authors:  A Lee; J Fox; S Hazell
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

3.  Characterization of Helicobacter pylori urease mutants.

Authors:  E D Segal; J Shon; L S Tompkins
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  Purification of recombinant Helicobacter pylori urease apoenzyme encoded by ureA and ureB.

Authors:  L T Hu; P A Foxall; R Russell; H L Mobley
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

5.  New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice.

Authors:  M Karita; T Kouchiyama; K Okita; T Nakazawa
Journal:  Am J Gastroenterol       Date:  1991-11       Impact factor: 10.864

6.  Transformation of Helicobacter pylori by electroporation.

Authors:  E D Segal; L S Tompkins
Journal:  Biotechniques       Date:  1993-02       Impact factor: 1.993

7.  Genetic transformation in Helicobacter pylori.

Authors:  M Tsuda; M Karita; T Nakazawa
Journal:  Microbiol Immunol       Date:  1993       Impact factor: 1.955

8.  Construction of isogenic urease-negative mutants of Helicobacter pylori by allelic exchange.

Authors:  R L Ferrero; V Cussac; P Courcoux; A Labigne
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

9.  Characteristics of Helicobacter pylori variants selected for urease deficiency.

Authors:  G I Pérez-Pérez; A Z Olivares; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

10.  Cloning and genetic characterization of the Helicobacter pylori and Helicobacter mustelae flaB flagellin genes and construction of H. pylori flaA- and flaB-negative mutants by electroporation-mediated allelic exchange.

Authors:  S Suerbaum; C Josenhans; A Labigne
Journal:  J Bacteriol       Date:  1993-06       Impact factor: 3.490

View more
  108 in total

1.  Membrane topology of the NixA nickel transporter of Helicobacter pylori: two nickel transport-specific motifs within transmembrane helices II and III.

Authors:  J F Fulkerson; H L Mobley
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

2.  Local pH elevation mediated by the intrabacterial urease of Helicobacter pylori cocultured with gastric cells.

Authors:  C Athmann; N Zeng; T Kang; E A Marcus; D R Scott; M Rektorschek; A Buhmann; K Melchers; G Sachs
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level.

Authors:  A H van Vliet; E J Kuipers; B Waidner; B J Davies; N de Vries; C W Penn; C M Vandenbroucke-Grauls; M Kist; S Bereswill; J G Kusters
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  An ABC transporter and a TonB ortholog contribute to Helicobacter mustelae nickel and cobalt acquisition.

Authors:  Jeroen Stoof; Ernst J Kuipers; Gerard Klaver; Arnoud H M van Vliet
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

5.  The urease enzyme of Helicobacter pylori does not function as an adhesin.

Authors:  M Clyne; B Drumm
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

6.  Allelic exchange mutagenesis of nixA in Helicobacter pylori results in reduced nickel transport and urease activity.

Authors:  P Bauerfeind; R M Garner; L T Mobley
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

7.  Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin.

Authors:  E Papini; B Satin; N Norais; M de Bernard; J L Telford; R Rappuoli; C Montecucco
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

8.  Cloning and characterization of hemolytic genes from Helicobacter pylori.

Authors:  E S Drazek; A Dubois; R K Holmes; D Kersulyte; N S Akopyants; D E Berg; R L Warren
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Inability of an isogenic urease-negative mutant stain of Helicobacter mustelae to colonize the ferret stomach.

Authors:  K A Andrutis; J G Fox; D B Schauer; R P Marini; J C Murphy; L Yan; J V Solnick
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Construction and characterization of an isogenic urease-negative mutant of Helicobacter mustelae.

Authors:  J V Solnick; C Josenhans; S Suerbaum; L S Tompkins; A Labigne
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.